HFA Premium Access

Furosemide 2.0: a novel formulation of furosemide for subcutaneous administration.

Congress Presentation

About the speaker

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)
18 presentations
0 follower

3 more presentations in this session

Pharmacokinetics of furosemide following subcutaneous administration of a novel injectable formulation.

Speaker: Professor R. De Boer (Rotterdam, NL)

Thumbnail

Initial clinical experience with subcutaneous furosemide in patients with fluid overload.

Speaker: Doctor S. Russell (Durham, US)

Thumbnail

Rationale for and design of the SUBQ-HF clinical study.

Speaker: Professor G. Felker (Durham, US)

Thumbnail

Access the full session

Furosemide 2.0: furosemide for subcutaneous administration: a novel tool in the management of the pre and post acute heart failure patient

Speakers: Professor B. Pitt, Professor R. De Boer, Doctor S. Russell, Professor G. Felker
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk